Oxford AstraZeneca vaccine granted Emergency Use Listing : WHO

▴ Oxford AstraZeneca vaccine granted Emergency Use Listing : WHO
As the vaccine earns approval from WHO now it is eligible for distribution in low and middle-income countries

Paving the way for Covid-19 vaccines to be distributed to low-income countries, the World Health Organisation on Monday granted emergency use listing (EUL) for the Oxford-Astrazeneca coronavirus vaccine manufactured by India's Serum Institute and South Korea's AstraZeneca-SKBio.

The authorisation will allow SII, the world’s biggest vaccine maker, to begin supplies of the Oxford vaccine to the WHO-backed COVAX initiative. Some 190 countries have joined the programme, which was established to ensure equitable distribution of vaccines.

Earlier, Serum Institute CEO Adar Poonawalla had said it would sell each dose at $3 for low-income countries. Besides the Oxford vaccine, WHO listed Pfizer and BioNTech's Covid-19 shot for emergency use on December 31.

The approval came after WHO's Strategic Advisory Group of Experts on Immunization (SAGE) reviewed the vaccine on February 8. The SAGE has recommended the vaccine for all age groups 18 and above.

"Countries with no access to vaccines to date will finally be able to start vaccinating their health workers and populations at risk, contributing to the COVAX Facility’s goal of equitable vaccine distribution," Dr Mariângela Simão, WHO Assistant-Director General for Access to Medicines and Health Products, said in a statement.

What does emergency use listing by WHO mean?
An EUL by WHO is an endorsement of sorts that will enable speedy pick-up of the vaccine by countries that lack an elaborate regulatory setup. According to WHO, its Emergency Use Listing assesses the quality, safety and efficacy of Covid-19 vaccines and is a prerequisite for COVAX Facility vaccine supply. It also allows countries to expedite their own regulatory approval to import and administer Covid-19 vaccines.

In the case of the AstraZeneca/Oxford vaccine, WHO assessed the quality, safety and efficacy data, risk management plans and programmatic suitability, such as cold chain requirements, the statement said. The process took four weeks.

Story Credit

https://www.indiatoday.in/coronavirus-outbreak/story/serum-institute-who-emergency-use-listing-oxford-covid-vaccine-1769586-2021-02-15 

Tags : #OxfordUniversity #AstraZeneca #WHO #VaccineApproval #LowandMiddleincomeCountries #SerumInstitute #AdarPoonawala

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

FDA Confirms Bird Flu Virus Remnants in Pasteurized Milk: Safety and Regulatory InsightsApril 24, 2024
Sarvodaya Hospital Redefines Total Knee Replacement Surgery with Augmented Reality April 23, 2024
Fateh Education announces partnership to expand educational opportunities for Indian studentsApril 23, 2024
10 Strategies to counter disinformation for the healthcare digital ecosystemApril 23, 2024
Is Selling Over-the-Counter (OTC) Drugs in General Stores A Step Towards Affordable Healthcare in IndiaApril 23, 2024
Student Health Crisis: Food Poisoning Incident Strikes Pune Coaching CentreApril 23, 2024
The Impact of Diabetes on Kidney Health: Diabetic Nephropathy ExplainedApril 23, 2024
Toddler Hospitalized After Consuming Expired Chocolates: Health Concerns RaisedApril 23, 2024
After months of diagnostic delay, a migrant worker could access TB services only when a community health worker met himApril 22, 2024
Indian Spices Contaminated with Cancer-Causing Chemical: Hong Kong Food Regulators Issue WarningApril 22, 2024
FTCCI organised a Workshop on Rooftop Kitchen GardeningApril 20, 2024
Children in Cities Exposed to Elevated Lead Levels: Study Reveals Urgent Health ConcernApril 20, 2024
Biocon Ventures into Weight-Loss Drug Market with Semaglutide DevelopmentApril 20, 2024
Innovative AI Assistance Empowers Moscow Doctors to Detect Cervical Spine Issues through MRI ScansApril 20, 2024
Air India Express ties up with AISATS for AeroWash Automated Aircraft Exterior Cleanings April 19, 2024
IndoSup raises strategic funding led by CCI group promoters Naresh Sharma and Satish Sharma; investors include Yatra.com’s Rohan Mittal April 19, 2024
10 compelling reasons why choosing right media platform Is important in healthcareApril 19, 2024
Protecting Public Health: Proposed Guidelines for Pharmaceutical Product DistributionApril 19, 2024
What is Haemophilia: A Genetic Bleeding Disorder that has Affected 1,36,000 IndiansApril 19, 2024
Climate Change and Stroke Risk: Exploring the Impact of Temperature Fluctuations on Your Body April 19, 2024